Q4 2021 Seres Therapeutics Inc Earnings Call Transcript
Ladies and gentlemen thank you for standing by and welcome to the Fourth Quarter 2021 Seres Therapeutics Inc. Earnings Conference Call. (Operator Instructions)
It is now pleasure to introduce Dr. Carlo Tanzi of Investor Relations.
Thank you and good morning. Our press release with the company's fourth quarter 2021 financial results and a business update became available at 7:00 a.m. Eastern Time this morning and can be found on the new Investors and News section of the company's website.
I'd like to remind you that we'll be making forward-looking statements related to the timing, enrollment and results of our clinical studies, the anticipated safety profile of our products, the timing of potential regulatory approval of SER-109, the success of our agreement with Nestle Health Science, the anticipated market for SER-109 and the promise and potential impact of any of our microbiome therapeutics.
Actual results may differ materially. Additionally, these statements are subject to
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
